Increased serum concentration of BAFF/APRIL and IgA2 subclass in patients with mixed connective tissue disease complicated by interstitial lung disease

References

• Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52(2):148–59.
   PubMed Web of Science ®Google Scholar
• Pettersson I, Wang G, Smith EI, Wigzell H, Hedfors E, Horn J, Sharp GC. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional, longitudinal study. Arthritis Rheum. 1986;29(8):986–96.
   PubMedGoogle Scholar
• Hoffman RW, Cassidy JT, Takeda Y, Smith-Jones EI, Wang GS, Sharp GC. U1-70-kd autoantibody-positive mixed connective tissue disease in children. A longitudinal clinical and serologic analysis. Arthritis Rheum. 1993;36(11):1599–602.
   PubMedGoogle Scholar
• Prakash UB. Respiratory complications in mixed connective tissue disease. Clin Chest Med. 1998;19(4):733–46, ix.
   PubMed Web of Science ®Google Scholar
• Sullivan WD, Hurst DJ, Harmon CE, Esther JH, Agia GA, Maltby JD, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore). 1984;63(2):92–107.
   PubMed Web of Science ®Google Scholar
• Grant KD, Adams LE, Hess EV. Mixed connective tissue disease - a subset with sequential clinical and laboratory features. J Rheumatol. 1981;8(4):587–98.
   PubMed Web of Science ®Google Scholar
• Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999; 42(5):899–909.
   PubMedGoogle Scholar
• Weinrib L, Sharma OP, Quismorio FP Jr. A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum. 1990;20(1):48–56.
   PubMed Web of Science ®Google Scholar
• Boulware DW, Hedgpeth MT. Lupus pneumonitis and anti-SSA(Ro) antibodies. J Rheumatol. 1989;16(4):479–81.
   PubMed Web of Science ®Google Scholar
• Krystufková O, Vallerskog T, Helmers SB, Mann H, Putová I, Belácek J, et al. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Ann Rheum Dis. 2009;68(6):836–43.
   PubMed Web of Science ®Google Scholar
• Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Xu D, et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 2003;48(12):3475–86.
   PubMed Web of Science ®Google Scholar
• Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ, Weyand CM. BLyS and APRIL in rheumatoid arthritis. J Clin Invest. 2005;115(11):3083–92.
   PubMed Web of Science ®Google Scholar
• Matsushita T, Hasegawa M, Yanaba K, Kodera M, Takehara K, Sato S. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes. Arthritis Rheum. 2006;54(1):192–201.
   PubMedGoogle Scholar
• Koyama T, Tsukamoto H, Miyagi Y, Himeji D, Otsuka J, Miyagawa H, et al. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann Rheum Dis. 2005;64(7):1065–7.
   PubMed Web of Science ®Google Scholar
• Szodoray P, Jonsson R. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjogren's syndrome. Scand J Immunol. 2005;62(5):421–8.
   PubMed Web of Science ®Google Scholar
• Fanburg-Smith JC, Furlong MA, Childers EL. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases. Mod Pathol. 2003;16(3):263–71.
   PubMed Web of Science ®Google Scholar
• Conley ME, Koopman WJ. In vitro regulation of IgA subclass synthesis. I. Discordance between plasma cell production and antibody secretion. JExp Med. 1982;156(6):1615–21.
   Google Scholar
• Stavnezer J. Antibody class switching. Adv Immunol. 1996;61:79–146.
   PubMed Web of Science ®Google Scholar
• Fayette J, Dubois B, Vandenabeele S, Bridon JM, Vanbervliet B, Durand I, et al. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J Exp Med. 1997;185(11):1909–18.
   PubMed Web of Science ®Google Scholar
• Kerr MA. The structure and function of human IgA. Biochem J. 1990;271(2):285–96.
   PubMed Web of Science ®Google Scholar
• Mestecky J, Russell MW, Elson CO. Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut. 1999;44(1):2–5.
   PubMed Web of Science ®Google Scholar
• Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp G, editors. Mixed Connective Tissue Disease and Antinuclear Antibodies. Amsterdam: Elsevier; 1987. p. 41–7.
   Google Scholar
• Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci U S A. 2004;101(11):3903–8.
   PubMed Web of Science ®Google Scholar
• Bielecki M, Kowal K, Lapinska A, Bernatowicz P, Chyczewski L, Kowal-Bielecka O. Increased production of a proliferation-inducing ligand (APRIL) by peripheral blood mononuclear cells is associated with antitopoisomerase I antibody and more severe disease in systemic sclerosis. J Rheumatol. 2010;37(11):2286–9.
   PubMed Web of Science ®Google Scholar
• Kreuzaler M, Rauch M, Salzer U, Birmelin J, Rizzi M, Grimbacher B, et al. Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors. J Immunol. 2012;188(1):497–503.
   PubMed Web of Science ®Google Scholar
• McCarthy DD, Kujawa J, Wilson C, Papandile A, Poreci U, Porfilio EA, et al. Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest. 2011; 121(10):3991–4002.
   PubMed Web of Science ®Google Scholar
• Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002;3(9):822–9.
   PubMed Web of Science ®Google Scholar
• Matsushita T, Hasegawa M, Yanaba K, Kodera M, Takehara K, Sato S. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes. Arthritis Rheum. 2006;54(1):192–201.
   PubMedGoogle Scholar